Australian Government Proposes $590 Million Cut to R&D Tax Incentives
Proposed legislative changes aim to restrict R&D tax offsets for long-standing small businesses.
1Proposed Legislative Budget Cuts
The Australian federal government plans to save $590 million by 2030 through reforms to the R&D tax incentive scheme. Currently, over 13,000 companies utilize this program, which cost the federal budget A$4.3 billion in 2024–25. The bill has passed the House of Representatives and now awaits a critical vote in the Senate.
2New Eligibility Age Limits
The government intends to stop small businesses from accessing refundable tax offsets once they have operated for ten years. For firms developing therapeutic goods, this limit is extended to 15 years. These changes, scheduled for June 1, 2028, aim to ensure tax breaks are not claimed indefinitely by established, mature companies.
3Indirect Activity Claim Restrictions
Companies will no longer be able to claim tax breaks for activities that only indirectly support their core R&D work. For instance, while drug testing remains eligible, costs for maintaining laboratory equipment used in those experiments may be excluded. This shift significantly narrows the scope of what businesses can legally claim.
4Impact on Life Sciences
Innovative life science firms developing vaccines and medical technologies face potential tax offset reductions of up to 60% under the new rules. While the 15-year limit for therapeutic goods was a concession to biotechnology industry lobbying, many startups argue that age-based caps hinder long-term research and development efforts in Australia.
5Broader Economic Policy Context
The government is under pressure to reduce spending to combat persistent inflation despite five interest rate hikes this year. Critics, including former industry minister Ed Husic, argue that the Treasury views R&D as a cost rather than an investment. They warn that reduced support could further lower Australia's already below-average R&D spending.
6Senate Voting Dynamics
Coalition MPs opposed the bill in the House, making Senate support unlikely from that bloc. The Greens hold a potentially decisive position and have signaled they will only support the bill if large oil and gas producers are restricted from claiming offsets. This creates a complex political trade-off for the government.
7Potential Strategic Compromises
If the government compromises with the Greens to restrict oil and gas companies, it could secure the bill's passage but face backlash from the energy sector. Another point of contention remains the ten-year age limit, with some stakeholders arguing it should be raised to 15 years to match therapeutic goods standards.
8Innovation and Future Risks
The government seeks to ensure tax breaks produce tangible benefits for Australia while curbing costs. However, the policy risks stifling homegrown innovation by limiting crucial funding for startups. Policymakers must balance fiscal responsibility with the need to support early-stage companies that require long-term financial stability to bring complex products to market.